NMN
Also known as: Nicotinamide Mononucleotide, Beta-NMN
A NAD+ precursor driving longevity research — showing early promise for energy, metabolic health, and anti-aging applications.
What it is
Nicotinamide mononucleotide (NMN) is a nucleotide naturally present in small amounts in food and a direct precursor to NAD+ (nicotinamide adenine dinucleotide). NAD+ is a coenzyme essential for energy metabolism, DNA repair, and sirtuin activation — proteins central to longevity research. NAD+ levels decline approximately 50% by middle age, and NMN supplementation represents one approach to restoring them.
How it works
NMN is absorbed and converted to NAD+ in cells, where it fuels mitochondrial electron transport, activates SIRT1/SIRT3 sirtuins (which regulate metabolism, stress resistance, and circadian rhythms), and provides ADP-ribose for DNA repair enzymes (PARPs). Human clinical trials (2020–2024) demonstrate improved NAD+ levels, muscle endurance, insulin sensitivity, and cardiovascular function — though these are early-phase studies with small sample sizes.
Clinical dose range
250–1,000 mg/day
Most human trials use 250–500 mg/day. Older adults show the greatest benefit. Some research suggests morning dosing aligns with circadian NAD+ rhythms. Sublingual NMN may have superior absorption over oral. Cost significantly limits real-world use at higher doses.
Forms comparison
What to look for on the label
- Beta-NMN purity ≥99% (avoid D-form NMN)
- Third-party tested for identity and purity — NMN market has significant adulteration problems
- Cold storage recommended — NMN degrades at room temperature over time
- Transparent dose on label; avoid proprietary blends hiding NMN dose within a stack
Health goals supported
Safety & dosing notes
No significant adverse effects observed in clinical trials up to 1,250 mg/day. Long-term safety data is limited compared to more established supplements. A theoretical concern exists regarding NAD+-driven PARP activity in cancer biology — not yet a clinical concern at supplemental doses, but worth monitoring as research matures.
SuppsBuddy marks NMN as emerging evidence and communicates this clearly in the analysis. Third-party purity verification is treated as essential given documented adulteration in the NMN market. Products without verified ≥99% beta-NMN purity receive significantly reduced ingredient quality scores.
Frequently asked questions
What is NMN?
Nicotinamide mononucleotide (NMN) is a nucleotide naturally present in small amounts in food and a direct precursor to NAD+ (nicotinamide adenine dinucleotide). NAD+ is a coenzyme essential for energy metabolism, DNA repair, and sirtuin activation — proteins central to longevity research. NAD+ levels decline approximately 50% by middle age, and NMN supplementation represents one approach to restoring them.
How does NMN work?
NMN is absorbed and converted to NAD+ in cells, where it fuels mitochondrial electron transport, activates SIRT1/SIRT3 sirtuins (which regulate metabolism, stress resistance, and circadian rhythms), and provides ADP-ribose for DNA repair enzymes (PARPs). Human clinical trials (2020–2024) demonstrate improved NAD+ levels, muscle endurance, insulin sensitivity, and cardiovascular function — though these are early-phase studies with small sample sizes.
What is the typical clinical dose range for NMN?
250–1,000 mg/day. Most human trials use 250–500 mg/day. Older adults show the greatest benefit. Some research suggests morning dosing aligns with circadian NAD+ rhythms. Sublingual NMN may have superior absorption over oral. Cost significantly limits real-world use at higher doses.
What forms of NMN should I look for?
Sublingual NMN powder or tablet: Bypasses first-pass metabolism; pharmacokinetic data supports faster absorption and higher peak NAD+ levels | Oral NMN capsules: Standard well-studied form; human trials confirm oral bioavailability and NAD+ elevation | Liposomal NMN: Enhanced delivery claimed; less clinical data than oral capsule form
Is NMN safe?
No significant adverse effects observed in clinical trials up to 1,250 mg/day. Long-term safety data is limited compared to more established supplements. A theoretical concern exists regarding NAD+-driven PARP activity in cancer biology — not yet a clinical concern at supplemental doses, but worth monitoring as research matures. This information is educational and is not medical advice.
How does SuppsBuddy evaluate NMN?
SuppsBuddy marks NMN as emerging evidence and communicates this clearly in the analysis. Third-party purity verification is treated as essential given documented adulteration in the NMN market. Products without verified ≥99% beta-NMN purity receive significantly reduced ingredient quality scores.
Related ingredients
This page is for educational purposes only. These statements have not been evaluated by the FDA. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any supplement.